VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Approved clinical indication for pectoral          │ Approved clinical indication for pectoral          │     100 │
│ pacemaker exchange (e.g. elective replacement      │ pacemaker exchange (e.g. elective replacement      │         │
│ indication (ERI), end of service (EOS))            │ indication (ERI), end of service (EOS))            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ a single or dual chamber MRI conditional pacemaker │ a single or dual chamber MRI conditional pacemaker │     100 │
│ (BSCI) or                                          │ (BSCI) or                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Any comparable successor IPG (MRI conditional      │ Any comparable successor IPG (MRI conditional      │     100 │
│ system, BSCI) compatible with                      │ system, BSCI) compatible with                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Implanted Fineline-II-leads (BSCI), MRI            │ Implanted Fineline-II-leads (BSCI), MRI            │     100 │
│ conditional                                        │ conditional                                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ The ascertained lead impedance is between 200 and  │ The ascertained lead impedance is between 200 and  │     100 │
│ 1500 Ohm                                           │ 1500 Ohm                                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ All pacing capture thresholds (PCT) do not exceed  │ All pacing capture thresholds (PCT) do not exceed  │     100 │
│ 2.0 V @0.4 or 0.5 ms in pacemaker dependent        │ 2.0 V @0.4 or 0.5 ms in pacemaker dependent        │         │
│ patients                                           │ patients                                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Male or female 18 years or older                   │ Male or female 18 years or older                   │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Understand the nature of the procedure             │ Understand the nature of the procedure             │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Give written informed consent                      │ Give written informed consent                      │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Able to complete all testing required by the       │ Able to complete all testing required by the       │     100 │
│ clinical protocol                                  │ clinical protocol                                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Ability to measure atrial and/or ventricular       │ Ability to measure atrial and/or ventricular       │     100 │
│ pacing threshold(s) at 0.4 or 0.5 ms               │ pacing threshold(s) at 0.4 or 0.5 ms               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient body height greater or equal to 140 cm     │ Patient body height greater or equal to 140 cm     │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pectoral implanted device                          │ Pectoral implanted device                          │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subjects who are able and willing to undergo       │ Subjects who are able and willing to undergo       │     100 │
│ elective cardiac magnetic resonance (MR) scanning  │ elective cardiac magnetic resonance (MR) scanning  │         │
│ without sedation (MRI-group)                       │ without sedation (MRI-group)                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subjects who are geographically stable and         │ Subjects who are geographically stable and         │     100 │
│ available for follow-up at the study center for    │ available for follow-up at the study center for    │         │
│ the length of the study                            │ the length of the study                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pacing threshold(s) (at 0.4 or 0.5 ms) and/or      │ Pacing threshold(s) (at 0.4 or 0.5 ms) and/or      │     100 │
│ sensing amplitude(s) and/or impedance(s) are not   │ sensing amplitude(s) and/or impedance(s) are not   │         │
│ measurable                                         │ measurable                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Meet one or more of the contraindications for MRI  │ Meet one or more of the contraindications for MRI  │     100 │
│ including Psychiatric disorders, anxiety,          │ including Psychiatric disorders, anxiety,          │         │
│ claustrophobia Cardiac disorders that represent a  │ claustrophobia Cardiac disorders that represent a  │         │
│ contraindication to MRI                            │ contraindication to MRI                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Cardiac surgery already scheduled in the next      │ Cardiac surgery already scheduled in the next      │     100 │
│ three months                                       │ three months                                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Have other medical implants that may interact with │ Have other medical implants that may interact with │     100 │
│ MRI, e.g. abandoned implantable cardioverter       │ MRI, e.g. abandoned implantable cardioverter       │         │
│ defibrillator (ICD) leads or pacemaker leads other │ defibrillator (ICD) leads or pacemaker leads other │         │
│ than MRI conditional, lead extensions, other       │ than MRI conditional, lead extensions, other       │         │
│ active medical devices, non-MRI compatible         │ active medical devices, non-MRI compatible         │         │
│ devices, mechanical valve                          │ devices, mechanical valve                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Have other metallic artifacts/components in body   │ Have other metallic artifacts/components in body   │     100 │
│ that may interact with MRI                         │ that may interact with MRI                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subjects for whom a single dose of 1.0 milligram   │ Subjects for whom a single dose of 1.0 milligram   │     100 │
│ (mg) dexamethasone acetate may be contraindicated  │ (mg) dexamethasone acetate may be contraindicated  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subjects who require a legally authorized          │ Subjects who require a legally authorized          │     100 │
│ representative to obtain consent                   │ representative to obtain consent                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subjects who are immediate candidates for an ICD   │ Subjects who are immediate candidates for an ICD   │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subjects with medical conditions that preclude the │ Subjects with medical conditions that preclude the │     100 │
│ testing required by the protocol or limit study    │ testing required by the protocol or limit study    │         │
│ participation                                      │ participation                                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subjects who are enrolled or intend to participate │ Subjects who are enrolled or intend to participate │     100 │
│ in another clinical trial (of an investigational   │ in another clinical trial (of an investigational   │         │
│ drug or device, new indication for an approved     │ drug or device, new indication for an approved     │         │
│ drug or device, or requirement of additional       │ drug or device, or requirement of additional       │         │
│ testing beyond standard clinical practice) during  │ testing beyond standard clinical practice) during  │         │
│ this clinical study                                │ this clinical study                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Being pregnant                                     │ Being pregnant                                     │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Have a life expectancy of less than three months   │ Have a life expectancy of less than three months   │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subjects with exclusion criteria required by local │ Subjects with exclusion criteria required by local │     100 │
│ law (e.g. age, breastfeeding)                      │ law (e.g. age, breastfeeding)                      │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒══════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                │ CHIA Criteria                                      │   Score │
╞══════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Leads electrically intact and with stable and    │ Have other metallic artifacts/components in body   │      43 │
│ normal function                                  │ that may interact with MRI                         │         │
├──────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 18 Years                │ Male or female 18 years or older                   │      46 │
├──────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Adherence to the MRI conditions of use is given  │ a single or dual chamber MRI conditional pacemaker │      47 │
│                                                  │ (BSCI) or                                          │         │
├──────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ • Non MRI conditional leads implanted            │ Pectoral implanted device                          │      48 │
├──────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Implantation of a CE certified / market released │ a single or dual chamber MRI conditional pacemaker │      61 │
│ MRI conditional pacemaker (BSCI) consistent of   │ (BSCI) or                                          │         │
╘══════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 95
Average Levenshtein Ratio of individual lines: 92.27272727272727
OverAll Ratio: 93.63636363636363
